RMD Q1 2025 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$36B

Q1 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$1.2B+11.1% YoY

Gross Profit

$717M58.6% margin

Operating Income

$387M31.6% margin

Net Income

$311M25.4% margin

EPS (Diluted)

$2.11

QoQ Revenue Growth

+0.1%

Cash Flow

Operating Cash Flow

$326M

Free Cash Flow

$306M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$7.2B

Total Liabilities

$2.0B

Stockholders' Equity

$5.2B

Cash & Equivalents

$426M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$1.1B	+11.1%
Gross Profit	$717M	$600M	+19.5%
Operating Income	$387M	$289M	+34.0%
Net Income	$311M	$219M	+41.9%

Revenue Segments

Sleep And Respiratory

$1.1B87%

Residential Care Software

$157M13%

Geographic Segments

Us Canada And Latin America

$707M58%

Combined Europe Asia And Other Markets

$360M29%

Global

$157M13%